1 month Is Eli Lilly Stock A Buy After FDA Pushes Back On Compounded Knockoffs? Investor's Business Daily
Eli Lilly stock is trending lower in December, but an FDA decision will keep compounders from making tirzepatide. Is Lilly stock a buy?
The post Is Eli Lilly Stock A Buy After FDA Pushes Back On Compounded Knockoffs? appeared first on Investor's B…